Julian Harrison

Stock Analyst at BTIG

(4.06)
# 512
Out of 5,041 analysts
57
Total ratings
62%
Success rate
10.47%
Average return

Stocks Rated by Julian Harrison

Climb Bio
Oct 16, 2025
Reiterates: Buy
Price Target: $8
Current: $1.99
Upside: +302.01%
Tvardi Therapeutics
Oct 13, 2025
Maintains: Buy
Price Target: $55$15
Current: $4.97
Upside: +201.81%
Apogee Therapeutics
Oct 9, 2025
Reiterates: Buy
Price Target: $115
Current: $53.32
Upside: +115.68%
Jade Biosciences
Oct 9, 2025
Initiates: Buy
Price Target: $28
Current: $10.00
Upside: +180.00%
ABIVAX Société Anonyme
Oct 7, 2025
Maintains: Buy
Price Target: $112$120
Current: $90.76
Upside: +32.22%
MoonLake Immunotherapeutics
Sep 29, 2025
Downgrades: Neutral
Price Target: $85
Current: $9.52
Upside: +792.86%
Oruka Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $56
Current: $27.22
Upside: +105.73%
Avalo Therapeutics
Sep 29, 2025
Reiterates: Buy
Price Target: $40
Current: $17.57
Upside: +127.66%
Nektar Therapeutics
Sep 19, 2025
Reiterates: Buy
Price Target: $100
Current: $60.10
Upside: +66.39%
Rezolute
Sep 18, 2025
Reiterates: Buy
Price Target: $17
Current: $9.19
Upside: +84.98%
Reiterates: Buy
Price Target: $70
Current: $23.37
Upside: +199.53%
Maintains: Buy
Price Target: $30$37
Current: $30.39
Upside: +21.75%
Reiterates: Buy
Price Target: $32
Current: $7.76
Upside: +312.37%
Maintains: Buy
Price Target: $24$25
Current: $14.25
Upside: +75.44%
Initiates: Buy
Price Target: $42
Current: $9.16
Upside: +358.52%
Downgrades: Neutral
Price Target: n/a
Current: $15.04
Upside: -
Downgrades: Neutral
Price Target: n/a
Current: $35.07
Upside: -
Maintains: Buy
Price Target: $50$9
Current: $1.39
Upside: +547.48%
Upgrades: Buy
Price Target: $8
Current: $2.15
Upside: +272.09%
Initiates: Buy
Price Target: $8
Current: $0.37
Upside: +2,043.05%
Maintains: Buy
Price Target: $56$61
Current: $22.16
Upside: +175.27%
Maintains: Buy
Price Target: $29$25
Current: $22.38
Upside: +11.71%
Maintains: Buy
Price Target: $41$51
Current: $74.86
Upside: -31.87%
Assumes: Buy
Price Target: $4
Current: $3.03
Upside: +32.01%
Reinstates: Buy
Price Target: $150
Current: $1.60
Upside: +9,275.00%
Initiates: Neutral
Price Target: n/a
Current: $418.58
Upside: -